EVT DE0005664809

Report

Real-time Estimate Tradegate - 05/26 03:59:59 pm
25.305	EUR		+2.33%

05/24	EVOTEC : Berenberg gives a Buy rating	MD
05/19	Evotec Working With Almirall to Develop New Therapies for Skin Diseases	MT
05/19	Evotec and Almirall enter into a multi-target alliance in medical dermatology	EQ

News

Press Releases

Official Publications

Sector news

Communiqués de presse de la société EVOTEC SE

05/19	Evotec and Almirall enter into a multi-target alliance in medical dermatology	EQ
05/18	Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell re..	AQ
05/17	Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based ..	AQ
05/17	Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell re..	EQ
05/11	Evotec SE reports results for the first quarter 2022 and provides corporate update	EQ
05/10	Evotec and Bristol Myers Squibb extend and expand strategic partnership	EQ
05/10	Evotec and Bristol Myers Squibb extend and expand strategic partnership in protein degr..	EQ
05/04	Evotec SE to announce results for the first quarter 2022 on 11 May 2022	EQ
05/03	EVOTEC : makes strategic equity investment in antibody drug conjugate specialist Tubulis	PU
04/26	EVOTEC : Sustainability Report 2021PDF, 3.9 MB	PU
04/13	Evotec SE fiscal year 2021 results, 'Setting the Pace' on the data-driven R&D Autobahn ..	AQ
04/12	EVOTEC SE FISCAL YEAR 2021 RESULTS : "Setting the Pace" on the data-driven R&D Autobahn to..	PU
04/12	EVOTEC SE FISCAL YEAR 2021 RESULTS : 'Setting the Pace' on the data-driven R&D Autobahn to..	EQ
04/08	Kazia - two abstracts at aacr conference present detailed study design and innovative b..	AQ
04/08	EVOTEC : achieves programme designation in neuroscience collaboration with Bristol Myers S..	PU
04/08	Evotec achieves programme designation in neuroscience collaboration with Bristol Myers ..	EQ
04/05	EVOTEC : to announce results for fiscal year 2021 on 12 April 2022	PU
04/05	Evotec SE to announce results for fiscal year 2021 on 12 April 2022	EQ
03/31	Evotec expands screening capacity at Hamburg headquarters through EFRE/REACT-EU-Grant	AQ
03/22	Evotec receives EUR 3 m milestone payment for Bayer starting Phase II clinical developm..	AQ
03/21	EVOTEC : receives € 3 m milestone payment for Bayer starting Phase II clinical development..	PU
03/21	Evotec receives ? 3 m milestone payment for Bayer starting Phase II clinical developmen..	EQ
03/14	EVOTEC : CMO Leadership Awards 2022	PU
03/08	EVOTEC : publishes DDup 12 - Evotec`s 3D cell model platform	PU
03/02	Evotec expands molecular patient database with unique nephrotic syndrome cohort from th..	AQ
03/02	UNIVERSITY OF BRISTOL : Bristol to collaborate with Evotec to help treatment of kidney dis..	AQ
03/02	EVOTEC : presents strategic roadmap towards precision medicine and confirms goals of Actio..	PU
03/02	Evotec presents strategic roadmap towards precision medicine and confirms goals of Acti..	EQ
03/01	Evotec expands molecular patient database with unique nephrotic syndrome cohort from th..	EQ
02/16	EVOTEC : participates in Centauri Therapeutics' Series A investment round	PU
02/15	EVOTEC : Invests In Data-Driven Biotechnology Company IMIDomics, Inc.	PU
02/07	Evotec SE - Bayer discontinues clinical development candidate eliapixant (BAY1817080), ..	AQ
02/04	EVOTEC SE : Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evo..	PU
02/04	Evotec expands sustainability at Dorothy Crowfoot Hodgkin Campus	AQ
02/04	EVOTEC SE : Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evo..	EQ
01/31	EVOTEC SE : Preliminary announcement of the publication of quarterly reports and quarterly..	EQ
01/25	EVOTEC SE : Notification and public disclosure of transactions by persons	EQ
01/25	Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophtha..	EQ
01/18	EVOTEC : partner Celmatix achieves milestone for PCOS drug programme	PU
01/18	Evotec and Lilly enter into drug discovery collaboration in metabolic diseases	EQ
01/11	EVOTEC : expands neuroscience collaboration with Bristol Myers Squibb to include new targe..	PU
01/11	Evotec expands neuroscience collaboration with Bristol Myers Squibb to include new targ..	EQ
01/04	EVOTEC SE : Notification and public disclosure of transactions by persons	EQ
01/04	Evotec receives EUR 7.5 m grant for development of COVID-19 therapeutic	AQ
01/03	EVOTEC : receives € 7.5 m grant for development of COVID-19 therapeutic	PU
01/03	Evotec receives ? 7.5 m grant for development of COVID-19 therapeutic	EQ
2021	EVOTEC : receives US$ 18 m grant for women's health	PU
2021	Evotec receives US$ 18 m grant for women's health	EQ
2021	EQRx and Evotec Announce Integrated Drug Discovery and Development Partnership	BU
2021	EVOTEC : and EQRx announce integrated drug discovery and development partnership	PU
2021	Evotec and EQRx announce integrated drug discovery and development partnership	EQ
2021	EVOTEC : announces the exercise of the Greenshoe option	PU
2021	Evotec SE reports results for the first nine months 2021 and provides corporate update	PU
2021	Evotec SE reports results for the first nine months 2021 and provides corporate update	EQ
2021	Evotec reaches programme designations in neuroscience collaboration with Bristol Myers ..	PU
2021	Evotec reaches programme designations in neuroscience collaboration with Bristol Myers ..	EQ
2021	Evotec SE announces closing of public offering	PU
2021	Evotec SE announces closing of public offering	EQ
2021	Evotec SE Announces Placement of its Public Offering of American Depositary Shares	PU
2021	Evotec SE to announce results for the first nine months 2021 on 11 November 2021	PU
2021	Evotec se to announce results for the first nine months 2021 on 11 november 2021	EQ
2021	Evotec SE - Translational BRIDGE beLAB2122 in collaboration with Bristol Myers Squibb i..	AQ
2021	EVOTEC SE : Translational BRIDGE beLAB2122 in collaboration with Bristol Myers Squibb iden..	PU
2021	Evotec announces first funded projects of translational BRIDGE beLAB1407 in collaborati..	PU
2021	Evotec SE announces launch of public offering of American Depositary Shares	PU
2021	EVOTEC SE : Announces launch of public offering of American Depositary Shares	EQ
2021	EVOTEC : provides preliminary nine month financial results	PU
2021	EVOTEC : provides preliminary nine month financial results	EQ
2021	EVOTEC : expands neuroscience collaboration with Bristol Myers Squibb to include novel cel..	AQ
2021	EVOTEC : LUMITOS AG - Evotec expands neuroscience collaboration with Bristol Myers Squibb ..	AQ
2021	EVOTEC : files registration statement for proposed offering of American Depositary Shares	PU
2021	EVOTEC : files registration statement for proposed offering of American Depositary Shares	EQ
2021	EVOTEC : expands neuroscience collaboration with Bristol Myers Squibb to include novel cel..	PU
2021	EVOTEC : expands neuroscience collaboration with Bristol Myers Squibb to include novel cel..	EQ
2021	EVOTEC : publishes DDup 11 – AI-driven antibody discovery at Evotec	PU

1 2 3 4 5 6 7 8 9 10 Next

Upcoming event on EVOTEC SE

06/22/22

Annual General Meeting

Company calendar

Upcoming sector events

07/26/22	IQVIA HOLDINGS INC. : Interim 2022 Earnings Release (Projected)
07/27/22	LONZA GROUP AG : Interim 2022 Earnings Release (Projected)
07/28/22	SEAGEN INC. : Interim 2022 Earnings Release (Projected)
08/10/22	MODERNA, INC. : Interim 2022 Earnings Release (Projected)

More events

Sector

Healthcare
	Pharmaceuticals & Medical Research
		Biotechnology & Medical Research
			Biotechnology & Medical Research
				Other Biotechnology & Medical Research